Vital Signs - In Acquisitions We Trust
Vital Signs - In Acquisitions We Trust
RELEASE DATE
12-Feb-2007
12-Feb-2007
REGION
North America
North America
Research Code: 9561-00-26-00-00
SKU: HC00470-NA-MR_03942
$1,500.00
In stock
SKU
HC00470-NA-MR_03942
Description
This issue of Vital Signs, released on February 12, 2007, provides a strategic overview of important acquisition criteria for M&A activities in the pharmaceutical industry. Additionally, an emerging company profile is provided for AmpliMed Corporation, a clinical stage pharmaceutical company specializing in small molecule oncology drugs. Reimbursement and regulatory news from the FDA and CMS is also provided for the week of January 29 - February 2, 2007.
Table of Contents
This week's issue:
Related Research
Popular Topics
This issue of Vital Signs, released on February 12, 2007, provides a strategic overview of important acquisition criteria for M&A activities in the pharmaceutical industry. Additionally, an emerging company profile is provided for AmpliMed Corporation, a clinical stage pharmaceutical company specializing in small molecule oncology drugs. Reimbursement and regulatory news from the FDA and CMS is also provided for the week of January 29 - February 2, 2007.
No Index | Yes |
---|---|
Podcast | No |
Industries | Healthcare |
WIP Number | 9561-00-26-00-00 |
Is Prebook | No |